ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ABDUL AL-KASSAB MD

Endocrinology, Diabetes Metabolism

8,584

$1.75M

1061
849 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 47%

$204
Average prescription price

Avg: $163

MOHAMMAD GHAFFARLOO M.D.

Endocrinology, Diabetes Metabolism

8,241

$851K

587
356 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

15%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 47%

$103
Average prescription price

Avg: $163

MANUEL CHAVARRI M.D.

Endocrinology, Diabetes Metabolism

7,502

$597K

397
307 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 47%

$80
Average prescription price

Avg: $163

DHIA YOUSIF MD

Endocrinology, Diabetes Metabolism

7,214

$430K

198
130 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

27%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 47%

$60
Average prescription price

Avg: $163

MAHMOOD MOOSA M.D.

Endocrinology, Diabetes Metabolism

6,106

$1.09M

644
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 47%

$178
Average prescription price

Avg: $163

ROBERT URBANIC M.D.

Endocrinology, Diabetes Metabolism

5,946

$440K

335
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 47%

$74
Average prescription price

Avg: $163

SLEMAN KHOURY MD

Endocrinology, Diabetes Metabolism

5,816

$1.02M

715
510 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 47%

$175
Average prescription price

Avg: $163

JUAN ESTIGARRIBIA

Endocrinology, Diabetes Metabolism

5,277

$357K

303
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 47%

$68
Average prescription price

Avg: $163

HASAN QUTOB MD

Endocrinology, Diabetes Metabolism

4,934

$1.05M

553
382 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 47%

$213
Average prescription price

Avg: $163

NASEER AHMAD M.D.

Endocrinology, Diabetes Metabolism

4,859

$511K

450
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 47%

$105
Average prescription price

Avg: $163

EDWARD KRYSHAK MD

Endocrinology, Diabetes Metabolism

4,604

$827K

712
534 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 47%

$180
Average prescription price

Avg: $163

BASHAR KIAMI M.D.

Endocrinology, Diabetes Metabolism

4,513

$803K

399
257 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 47%

$178
Average prescription price

Avg: $163

ALLA SAKHAROVA M.D.

Endocrinology, Diabetes Metabolism

4,448

$880K

446
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 47%

$198
Average prescription price

Avg: $163

SUSHMA REDDY MD

Endocrinology, Diabetes Metabolism

4,121

$850K

411
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 47%

$206
Average prescription price

Avg: $163

MAJDI AL-NAJJAR MD

Endocrinology, Diabetes Metabolism

3,919

$1.03M

441
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 47%

$263
Average prescription price

Avg: $163

ROBERT SELFE D.O.

Endocrinology, Diabetes Metabolism

3,882

$337K

328
195 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 47%

$87
Average prescription price

Avg: $163

CRAIG GREENBERG M.D.

Endocrinology, Diabetes Metabolism

3,839

$669K

414
249 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 47%

$174
Average prescription price

Avg: $163

MARGARETHE MACIULIS MD

Endocrinology, Diabetes Metabolism

3,697

$688K

375
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 47%

$186
Average prescription price

Avg: $163

SANDER PAUL M.D.

Endocrinology, Diabetes Metabolism

3,495

$687K

484
426 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 47%

$197
Average prescription price

Avg: $163

HEMANT THAWANI MD

Endocrinology, Diabetes Metabolism

3,495

$414K

386
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 47%

$118
Average prescription price

Avg: $163

ROBERT IGWE M.D.

Endocrinology, Diabetes Metabolism

3,287

$694K

420
313 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 47%

$211
Average prescription price

Avg: $163

ERIC LANGER DO

Endocrinology, Diabetes Metabolism

3,271

$554K

364
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 47%

$169
Average prescription price

Avg: $163

SMITA BIJLANI MD

Endocrinology, Diabetes Metabolism

2,923

$502K

426
355 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 47%

$172
Average prescription price

Avg: $163

NANCY ANDREWS DO

Endocrinology, Diabetes Metabolism

2,776

$503K

406
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 47%

$181
Average prescription price

Avg: $163

MAHALAKSHMI HONASOGE M.D.

Endocrinology, Diabetes Metabolism

2,523

$478K

357
278 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 47%

$189
Average prescription price

Avg: $163

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank